0001209191-16-100265.txt : 20160218
0001209191-16-100265.hdr.sgml : 20160218
20160218203653
ACCESSION NUMBER: 0001209191-16-100265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160216
FILED AS OF DATE: 20160218
DATE AS OF CHANGE: 20160218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
STREET 2: SUITE 100
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 510-521-3390
MAIL ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
STREET 2: SUITE 100
CITY: ALAMEDA
STATE: CA
ZIP: 94502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Last Andrew J.
CENTRAL INDEX KEY: 0001485088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 161439874
MAIL ADDRESS:
STREET 1: 3420 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-16
0
0001642380
OncoCyte Corp
OCX
0001485088
Last Andrew J.
3420 CENTRAL EXPRESSWAY
SANTA CLARA
CA
95051
1
0
0
0
Option to Purchase Common Stock
3.06
2016-02-16
4
A
0
20000
0.00
A
2026-02-15
Common Stock
20000
20000
D
Option to Purchase Common Stock
3.60
2025-12-14
Common Stock
10000
10000
D
Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant.
2,500 options became exercisable on December 31, 2015, and the remaining 7,500 options will become exercisable in three equal quarterly installments based upon continued service on the board of directors.
/s/Andrew J. Last
2016-02-18